Orchard Therapeutics | 4biocapital

NEWSROOM

Dec 22, 2020

Orchard Therapeutics Receives EC Approval for Treatment of Early-Onset Metachromatic Leukodystrophy

Feb 22, 2019

4BIO portfolio company Orchard Therapeutics announces ADA-SCID follow-on results

Nov 1, 2018

4BIO portfolio company Orchard Therapeutics goes public

Aug 13, 2018

4BIO portfolio company Orchard Therapeutics Announces $150 Million Series C Financing

Apr 13, 2018

GSK Hands Off Rare Disease Gene Therapy Portfolio to Orchard Therapeutics

Dec 20, 2017

4BIO Capital participates in $110M Series B Financing of Orchard Therapeutics